Wanqi Yang
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- Health top 5%
- Vaccine Coverage and Hesitancy
Papers in
-
- Natural product bioactivities and synthesis 3
- Protein Degradation and Inhibitors 3
-
- Geochemistry and Geologic Mapping 7
- Co-authors
- Minjie Li (3 shared papers)Lei Wang (3 shared papers)Zhiwei Wu (3 shared papers)Zhiwei Jiang (3 shared papers)Yuliang Zhao (2 shared papers)Yuzhu Ding (1 shared paper)Zhen Chen (1 shared paper)Hui Jin (1 shared paper)
In The Last Decade
Wanqi Yang
54 papers receiving 1.4k citations
Wanqi Yang's Hit Papers
Peers
Comparison fields: 5 of 125
- Infectious Diseases 486
- Health 164
- Cancer Research 129
- Obstetrics and Gynecology 59
- Modeling and Simulation 32
Countries citing papers authored by Wanqi Yang
This map shows the geographic impact of Wanqi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanqi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanqi Yang more than expected).
Fields of papers citing papers by Wanqi Yang
This network shows the impact of papers produced by Wanqi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanqi Yang. The network helps show where Wanqi Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanqi Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial Hit paper breakdown → | 2021 | 372 |
| 2 | Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial Hit paper breakdown → | 2021 | 217 |
| 3 | 2020 | 105 | |
| 4 | 2014 | 89 | |
| 5 | 2021 | 71 | |
| 6 | 2019 | 47 | |
| 7 | 2021 | 34 | |
| 8 | 2015 | 31 | |
| 9 | 2017 | 29 | |
| 10 | 2022 | 27 | |
| 11 | 2017 | 27 | |
| 12 | 2021 | 17 | |
| 13 | 2020 | 17 | |
| 14 | 2023 | 17 | |
| 15 | 2022 | 16 | |
| 16 | 2019 | 16 | |
| 17 | 2023 | 15 | |
| 18 | 2021 | 15 | |
| 19 | 2021 | 14 | |
| 20 | 2019 | 14 |
About Wanqi Yang
Wanqi Yang is a scholar working on Molecular Biology, Artificial Intelligence, Mechanical Engineering, Analytical Chemistry and Infectious Diseases, having authored 64 papers that have together received 1.4k indexed citations. Recurring topics across this work include Spectroscopy and Chemometric Analyses (8 papers), Mineral Processing and Grinding (8 papers), Geochemistry and Geologic Mapping (7 papers), Cancer-related molecular mechanisms research (4 papers), Natural product bioactivities and synthesis (3 papers), Viral gastroenteritis research and epidemiology (3 papers), Peptidase Inhibition and Analysis (3 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Infectious Diseases (486 citations), Health (164 citations), Cancer Research (129 citations), Obstetrics and Gynecology (59 citations) and Modeling and Simulation (32 citations). Wanqi Yang has collaborated with scholars based in China, Singapore and Taiwan. Frequent co-authors include Minjie Li, Lei Wang, Zhiwei Wu, Zhiwei Jiang, Yuliang Zhao, Yuzhu Ding, Zhen Chen, Hui Jin, Yaling Hu and Guoqing Zhao. Their work appears in journals such as Journal of Analytical Atomic Spectrometry, The Lancet Infectious Diseases, Talanta, Analytica Chimica Acta and Canadian Journal of Physiology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.